(PharmaNewsWire.Com, May 12, 2020 ) The ultrasound probe disinfection market is projected to reach USD 819.1 million by 2023 from an estimated USD 314.1 million in 2018, at a CAGR of 21.1%. The key factors driving the growth of this market include the increasing number of ultrasound imaging procedures, rising incidence of hospital-acquired infections due to the improper reprocessing of ultrasound probes, increasing adoption of high-level disinfection systems for critical and semi-critical ultrasound probes, and technological advancements in ultrasound probes.
Consumables segment is expected to account for the largest share of the ultrasound probe disinfection market, by product, in 2018
On the basis of product, the market is broadly segmented into consumables, instruments, and services. In 2018, the consumables segment is expected to account for the largest share of this market. This can majorly be attributed to the large number of commercially available disinfectants (as compared to other ultrasound probe disinfection products) in the market.
High-level disinfection segment is expected to register the highest CAGR in the market, by process, during the forecast period
Based on process, the market is segmented into high-level disinfection and intermediate/low-level disinfection. The high-level disinfection segment is estimated to register the highest CAGR during the forecast period. The growth of this segment is driven by the implementation of favorable government regulations and guidelines for effective probe disinfection, coupled with the growing incidence of HAIs.
Linear transducers segment is expected to account for the largest share of the ultrasound probe disinfection market, by type of probe, in 2018
On the basis of the type of probe, the market is broadly segmented into linear transducers, convex transducers, phased array transducers, endocavitary transducers, transesophageal echocardiography (TEE) transducers, and other probes (pencil transducers, concave transducers, and sector transducers). In 2018, the linear transducers segment is expected to account for the largest share of this market. Linear transducers are used for various applications, such as vascular examination, venipuncture, blood vessel visualization, intraoperative procedures, and laparoscopy. They come in contact with clean, intact skin, and are considered non-critical devices that require disinfection after every use and act as both a source and a vector for nosocomial infections.
Ambulatory care centers segment is expected to register the highest CAGR in the market, by end user, during the forecast period
Based on end user, the market is segmented into hospitals & diagnostic imaging centers, maternity centers, ambulatory care centers, academic & research institutes, and other end users (physiotherapists, independent associations, government organizations, and sports academies). The ambulatory care centers segment is estimated to register the highest CAGR during the forecast period. The high growth in this end-user segment can be attributed to the increasing number of image-guided surgeries performed at ambulatory care centers, rising market demand for portable and compact ultrasound devices, and the procedural benefits offered by ultrasound in PoC applications.
North America is expected to dominate the market in 2018
North America accounted for the largest share of the market in 2018, followed by Europe. The increasing number of transvaginal, transrectal, abdominal, and intraoperative ultrasound procedures; growing number of TEE and ultrasound-guided interventional procedures (biopsies and venous access); rising adoption of high-level disinfectants; and the presence of leading market players in the region are the major factors responsible for the large share of North America in the market.
The key players operating in the global market are Nanosonics (Australia), CIVCO Medical Solutions (US), Tristel (UK), Ecolab (US), Germitec (France), Parker Laboratories (US), Schülke & Mayr (Germany), CS Medical (US), Virox Technologies (Canada), STERIS (UK), Advanced Sterilization Products (US), and Metrex Research (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
